These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 20356993)

  • 1. How to treat children's pneumonia: a complex problem.
    Don M; Korppi M
    Eur Respir J; 2010 Apr; 35(4):932-3. PubMed ID: 20356993
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical and pharmacoeconomic perspective use of amoxicillin/sulbactam in the treatment of extra-hospital pneumonia].
    Sinopal'nikov AI; Zaĭtsev AA
    Voen Med Zh; 2006 Nov; 327(11):42-5. PubMed ID: 17300060
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparative randomized trial of azithromycin versus erythromycin and amoxicillin for treatment of community-acquired pneumonia in children.
    Kogan R; Martínez MA; Rubilar L; Payá E; Quevedo I; Puppo H; Girardi G; Castro-Rodriguez JA
    Pediatr Pulmonol; 2003 Feb; 35(2):91-8. PubMed ID: 12526069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness of H. pylori eradication.
    Roesch W
    J Physiol Pharmacol; 1996 Mar; 47(1):71-7. PubMed ID: 8777309
    [No Abstract]   [Full Text] [Related]  

  • 5. Oral versus i.v. antibiotics for community-acquired pneumonia in children: a cost-minimisation analysis.
    Lorgelly PK; Atkinson M; Lakhanpaul M; Smyth AR; Vyas H; Weston V; Stephenson T
    Eur Respir J; 2010 Apr; 35(4):858-64. PubMed ID: 19717479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A cost-effectiveness analysis of antimicrobial treatment of community-acquired pneumonia taking into account resistance in Belgium.
    Martin M; Moore L; Quilici S; Decramer M; Simoens S
    Curr Med Res Opin; 2008 Mar; 24(3):737-51. PubMed ID: 18230196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pneumonia: macrolides or amoxicillin for community acquired pneumonia?
    Marchetti F; Berti I
    BMJ; 2006 May; 332(7551):1213-4. PubMed ID: 16710005
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical and economic outcomes in respiratory tract infections: The impact of bacterial resistance.
    Rapp RP
    Postgrad Med; 2002 Sep; 112(3 Suppl):12-7. PubMed ID: 19667590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of intramuscular penicillin versus oral amoxicillin in the early treatment of outpatient pediatric pneumonia.
    Tsarouhas N; Shaw KN; Hodinka RL; Bell LM
    Pediatr Emerg Care; 1998 Oct; 14(5):338-41. PubMed ID: 9814400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and economic outcomes in the treatment of lower respiratory tract infections.
    Brixner DI
    Am J Manag Care; 2004 Oct; 10(12 Suppl):S400-7. PubMed ID: 15603249
    [No Abstract]   [Full Text] [Related]  

  • 11. Cefuroxime compared to amoxicillin-clavulanic acid in the treatment of community-acquired pneumonia.
    Oh HM; Ng AW; Lee SK
    Singapore Med J; 1996 Jun; 37(3):255-7. PubMed ID: 8942221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Community-acquired pneumonia: treatment at home or in the hospital?
    Aujesky D; Fine MJ
    Am J Med; 2008 Dec; 121(12):1038-40. PubMed ID: 19028194
    [No Abstract]   [Full Text] [Related]  

  • 13. [The clinical and pharmacoeconomic aspects of gemifloxacin(corrected) use in the patients with extra-hospital pneumonia in stationary conditions].
    Zaĭtsev AA; Sinopal'nikova AI
    Voen Med Zh; 2007 Jan; 328(1):44-51. PubMed ID: 17436714
    [No Abstract]   [Full Text] [Related]  

  • 14. Challenges in the design of antibiotic equivalency studies: the multicenter equivalency study of oral amoxicillin versus injectable penicillin in children aged 3-59 months with severe pneumonia.
    Hibberd PL; Patel A;
    Clin Infect Dis; 2004 Aug; 39(4):526-31. PubMed ID: 15356816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dealing with childhood pneumonia in developing countries: how can we make a difference?
    Bhutta ZA
    Arch Dis Child; 2007 Apr; 92(4):286-8. PubMed ID: 17376934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Enterobacter agglomerans pneumonia outside of the hospital in a previously health patient].
    García-Pardo G; Martí N; Vidal F; Richart C
    Enferm Infecc Microbiol Clin; 1999 Jan; 17(1):48. PubMed ID: 10069121
    [No Abstract]   [Full Text] [Related]  

  • 17. Antibiotic treatment of community acquired pneumonia in well-nourished young Nigerian children.
    Ajayi MT; Oladokun RA; Falade AG
    J Trop Pediatr; 2005 Oct; 51(5):319-20. PubMed ID: 15980026
    [No Abstract]   [Full Text] [Related]  

  • 18. Management of pneumonia.
    Mackay JB
    N Z Med J; 1979 Jun; 89(637):441-3. PubMed ID: 289020
    [No Abstract]   [Full Text] [Related]  

  • 19. Treatment failure rates and health care utilization and costs among patients with community-acquired pneumonia treated with levofloxacin or macrolides in an outpatient setting: a retrospective claims database analysis.
    Ye X; Sikirica V; Schein JR; Grant R; Zarotsky V; Doshi D; Benson CJ; Riedel AA
    Clin Ther; 2008 Feb; 30(2):358-71. PubMed ID: 18343274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pharmacoeconomic estimation of cost of community acquired pneumonia therapy].
    Kulidzhanov AIu; Sirotko II; Koriakin PM; Korchazhkin VS
    Voen Med Zh; 2001 Jan; 322(1):50-2. PubMed ID: 11219929
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.